Keyword Search Results for "NSTEACS"

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation. 1993;87:38-52. Abstract

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation. 1994;89:1545-56. Abstract

Becker, R. C., Bovill, E. G., Corrao, J. M., Ball, S. P., Ault, K., Mann, K., Tracy, R. P. Platelet Activation Determined by Flow Cytometry Persists Despite Antithrombotic Therapy in Patients with Unstable Angina and Non-Q-Wave Myocardial Infarction Journal of thrombosis and thrombolysis. 1994;1(1):95-100. Abstract

Diver, D. J., Bier, J. D., Ferreira, P. E., Sharaf, B. L., McCabe, C., Thompson, B., Chaitman, B., Williams, D. O., Braunwald, E. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial) American journal of cardiology. 1994;74(6):531-7. Abstract

Anderson, H. V., Cannon, C. P., Stone, P. H., Williams, D. O., McCabe, C. H., Knatterud, G. L., Thompson, B., Willerson, J. T., Braunwald, E. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction Journal of the American College of Cardiology. 1995;26(7):1643-50. Abstract

Cannon, C. P., Thompson, B., McCabe, C. H., Mueller, H. S., Kirshenbaum, J. M., Herson, S., Nasmith, J. B., Chaitman, B. R., Braunwald, E. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials American journal of cardiology. 1995;75(15):977-81. Abstract

Fuchs J, Cannon CP. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. Circulation. 1995;92:727-33. Abstract

Becker, R. C., Cannon, C. P., Bovill, E. G., Tracy, R. P., Thompson, B., Knatterud, G. L., Randall, A., Braunwald, B. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) American journal of cardiology. 1996;78(2):142-7. Abstract

Becker, R. C., Cannon, C. P., Tracy, R. P., Thompson, B., Bovill, E. G., Desvigne-Nickens, P., Randall, A. M., Knatternud, G., Braunwald, E. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators American heart journal. 1996;131(3):421-33. Abstract

Kleiman, N. S., Anderson, H. V., Rogers, W. J., Theroux, P., Thompson, B., Stone, P. H. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry) American journal of cardiology. 1996;77(4):227-31. Abstract

Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Théroux P, Warnica JW, Nasmith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braunwald E. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. J Am Med Assoc. 1996;275:1104-12. Abstract

Williams, D. O., Braunwald, E., Thompson, B., Sharaf, B. L., Buller, C. E., Knatterud, G. L. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial Circulation. 1996;94(11):2749-55. Abstract

Anderson, H. V., Gibson, R. S., Stone, P. H., Cannon, C. P., Aguirre, F., Thompson, B., Knatterud, G. L., Braunwald, E. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry) American journal of cardiology. 1997;79(11):1441-6. Abstract

Cannon, C. P., McCabe, C. H., Stone, P. H., Rogers, W. J., Schactman, M., Thompson, B. W., Pearce, D. J., Diver, D. J., Kells, C., Feldman, T., Williams, M., Gibson, R. S., Kronenberg, M. W., Ganz, L. I., Anderson, H. V., Braunwald, E. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia Journal of the American College of Cardiology. 1997;30(1):133-40. Abstract

Cannon, C. P., McCabe, C. H., Stone, P. H., Schactman, M., Thompson, B., Theroux, P., Gibson, R. S., Feldman, T., Kleiman, N. S., Tofler, G. H., Muller, J. E., Chaitman, B. R., Braunwald, E. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB) American journal of cardiology. 1997;79(3):253-8. Abstract

Hochman, J. S., McCabe, C. H., Stone, P. H., Becker, R. C., Cannon, C. P., DeFeo-Fraulini, T., Thompson, B., Steingart, R., Knatterud, G., Braunwald, E. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction Journal of the American College of Cardiology. 1997;30(1):141-8. Abstract

Jain, D., Thompson, B., Wackers, F. J., Zaret, B. L. Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study Journal of the American College of Cardiology. 1997;30(2):421-9. Abstract

The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators. Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. J Am Coll Cardiol. 1997;29:1474-82. Abstract

Antman, E. M. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators Am Heart J. 1998;135(6, Supplement 2):S353-60. Abstract

Antman, E. M., Sacks, D. B., Rifai, N., McCabe, C. H., Cannon, C. P., Braunwald, E. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy J Am Coll Cardiol. 1998;31(2):326-30. Abstract

Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Robertson, D. H., Gormley, G. J., Braunwald, E. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial Infarction Am J Cardiol. 1998;82(6):731-6. Abstract

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., Braunwald, E. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1998;31(7):1460-5. Abstract

Antman EM, McCabe CH, Gurfinkel EP, Turpie AG, Bernink PJ, Salein D, Bayes De Luna A, Fox K, Lablanche JM, Radley D, Premmereur J, Braunwald E. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation. 1999;100:1593-601. Abstract

Antman, E. M., Cohen, M., Radley, D., McCabe, C., Rush, J., Premmereur, J., Braunwald, E. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis Circulation. 1999;100(15):1602-8. Abstract

Gurfinkel, E. P., Scirica, B. M., Bozovich, G., Macchia, A., Manos, E., Mautner, B. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction Am J Cardiol. 1999;83(4):515-8. Abstract

Stone, P. H., Thompson, B., Zaret, B. L., Chaitman, B., Gibson, R. S., Schweiger, M. J., Steingart, R., Kirshenbaum, J., Thompson, C., Fung, A., McCabe, C. H., Knatterud, G. L., Braunwald, E. Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study European heart journal. 1999;20(15):1084-93. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease Clinical cardiology. 1999;22(1):13-6. Abstract

Weintraub, W. S., Culler, S. D., Kosinski, A., Becker, E. R., Mahoney, E., Burnette, J., Spertus, J. A., Feeny, D., Cohen, D. J., Krumholz, H., Ellis, S. G., Demopoulos, L., Robertson, D., Boccuzzi, S. J., Barr, E., Cannon, C. P. Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial Am J Cardiol. 1999;83(3):317-22. Abstract

Antman, E. M., Cohen, M., Bernink, P. J., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., Braunwald, E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA. 2000;284(7):835-42. Abstract

Morrow, D. A., Antman, E. M., Tanasijevic, M., Rifai, N., de Lemos, J. A., McCabe, C. H., Cannon, C. P., Braunwald, E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy J Am Coll Cardiol. 2000;36(6):1812-7. Abstract

Morrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., Braunwald, E. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy J Am Coll Cardiol. 2000;35(2):358-62. Abstract

Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87. Abstract

Cohen, M., Antman, E. M., Gurfinkel, E. P., Radley, D. Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups J Thromb Thrombolysis. 2001;12(3):199-206. Abstract

Henry, T. D., Satran, D., Knox, L. L., Iacarella, C. L., Laxson, D. D., Antman, E. M. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin? Am Heart J. 2001;142(4):590-3. Abstract

Holper, E. M., Antman, E. M., McCabe, C. H., Premmereur, J., Gurfinkel, E., Bernink, P. J., Turpie, A. G., Bayes de Luna, A., Lablanche, J. M., Fox, K. M., Salein, D., Radley, D. R., Braunwald, E. A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction Am J Cardiol. 2001;87(8):1008-10; A5.

Morrow, D. A., Cannon, C. P., Rifai, N., Frey, M. J., Vicari, R., Lakkis, N., Robertson, D. H., Hille, D. A., DeLucca, P. T., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA. 2001;286(19):2405-12. Abstract

Santopinto, J., Gurfinkel, E. P., Torres, V., Marcos, E., Bozovich, G. E., Mautner, B., McCabe, C. H., Antman, E. M. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin Am Heart J. 2001;141(4):566-72. Abstract

Solomon, D. H., Stone, P. H., Glynn, R. J., Ganz, D. A., Gibson, C. M., Tracy, R., Avorn, J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy Journal of the American College of Cardiology. 2001;38(4):969-76. Abstract

Antman EM, McCabe CH, Braunwald E. Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. Am Heart J. 2002;143:229-34. Abstract

Antman, E. M., Cohen, M., McCabe, C., Goodman, S. G., Murphy, S. A., Braunwald, E. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE Eur Heart J. 2002;23(4):308-14. Abstract

Becker, R. C., Spencer, F. A., Gibson, M., Rush, J. E., Sanderink, G., Murphy, S. A., Ball, S. P., Antman, E. M. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes Am Heart J. 2002;143(5):753-9. Abstract

Cohen, M., Antman, E. M., Murphy, S. A., Radley, D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes Am Heart J. 2002;143(1):63-9. Abstract

Fox, K. A., Antman, E. M., Cohen, M., Bigonzi, F. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention Am J Cardiol. 2002;90(5):477-82. Abstract

Gibson, C. M., Chen, M., Angeja, B. G., Murphy, S. A., Marble, S. J., Barron, H. V., Cannon, C. P. Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery J Thromb Thrombolysis. 2002;13(1):12-Sep. Abstract

Januzzi, J. L., Cannon, C. P., DiBattiste, P. M., Murphy, S., Weintraub, W., Braunwald, E. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial) Am J Cardiol. 2002;90(11):1246-9.

Kleiman, N. S., Lakkis, N., Cannon, C. P., Murphy, S. A., DiBattiste, P. M., Demopoulos, L. A., Weintraub, W. S., Braunwald, E. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes J Am Coll Cardiol. 2002;40(6):1044-50. Abstract

Lakkis, N., Tsyboulev, V., Gibson, C. M., Murphy, S. A., Weintraub, W. S., DiBattiste, P. M., Cannon, C. P. Outcome of patients with acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2002;1(4):232-7.

Mahoney, E. M., Jurkovitz, C. T., Chu, H., Becker, E. R., Culler, S., Kosinski, A. S., Robertson, D. H., Alexander, C., Nag, S., Cook, J. R., Demopoulos, L. A., DiBattiste, P. M., Cannon, C. P., Weintraub, W. S. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction JAMA. 2002;288(15):1851-8. Abstract

Morrow, D. A., Antman, E. M., Snapinn, S. M., McCabe, C. H., Theroux, P., Braunwald, E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS Eur Heart J. 2002;23(3):223-9. Abstract

Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., Braunwald, E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation. 2002;105(15):1760-3. Abstract

Scirica, B. M., Cannon, C. P., Antman, E. M., Murphy, S. A., Morrow, D. A., Sabatine, M. S., McCabe, C. H., Gibson, C. M., Braunwald, E. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry American journal of cardiology. 2002;90(3):303-5.

Scirica, B. M., Cannon, C. P., Gibson, C. M., Murphy, S. A., Moliterno, D. J., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., Ferguson, J. J., Braunwald, E. Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries Critical pathways in cardiology. 2002;1(3):150-8. Abstract

Scirica, B. M., Cannon, C. P., McCabe, C. H., Murphy, S. A., Anderson, H. V., Rogers, W. J., Stone, P. H., Braunwald, E., Thrombolysis in Myocardial Ischemia, I. I. I. Registry Investigators Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification Am J Cardiol. 2002;90(8):821-6. Abstract

Sharis, P. J., Cannon, C. P., Rogers, W. J., McCabe, C., Murphy, S., Gibson, C. M., Stone, P. H., Braunwald, E. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry) American journal of cardiology. 2002;90(10):1154-6.

Solomon, Daniel H., Ganz, David A., Avorn, Jerry, Glynn, Robert J., Knight, Eric L., Gibson, C. Michael, Stone, Peter H. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy Journal of Clinical Epidemiology. 2002;55(2):121-128.

de Lemos, J. A., Morrow, D. A., Gibson, C. M., Murphy, S. A., Sabatine, M. S., Rifai, N., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies J Am Coll Cardiol. 2002;40(2):238-44. Abstract

Braunwald, E. Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction Circulation. 2003;108(16 Suppl 1):III28-37. Abstract

Cannon, C. P. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial J Am Coll Cardiol. 2003;41(4 Suppl S):43S-48S. Abstract

Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Gibson, C. M., Cannon, C. P., Braunwald, E. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 J Am Coll Cardiol. 2003;41(8):1264-72.

Pinto, D. S., Lorenz, D. P., Murphy, S. A., Marble, S. J., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P., Gibson, C. M. Association of an activated clotting time < or =250 seconds with adverse event rates after percutaneous coronary intervention using tirofiban and heparin (a TACTICS-TIMI 18 substudy) Am J Cardiol. 2003;91(8):976-8, A4.

Spinler, S. A., Inverso, S. M., Cohen, M., Goodman, S. G., Stringer, K. A., Antman, E. M. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies Am Heart J. 2003;146(1):33-41. Abstract

Bach, R. G., Cannon, C. P., Weintraub, W. S., DiBattiste, P. M., Demopoulos, L. A., Anderson, H. V., DeLucca, P. T., Mahoney, E. M., Murphy, S. A., Braunwald, E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes Ann Intern Med. 2004;141(3):186-95.

Cannon, C. P. Utilization of guidelines and computer-based technology to achieve optimal care in atherothrombotic vascular disease J Thromb Thrombolysis. 2004;17(1):45-9. Abstract

Gibson, C. M., Singh, K. P., Murphy, S. A., DiBattiste, P. M., Demopoulos, L. A., Cannon, C. P., Braunwald, E. Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy) Am J Cardiol. 2004;94(4):492-4. Abstract

Herrmann, H. C., Murphy, S. A., Dibattiste, P. M., Delucca, P. T., Demopoulos, L. A., Gibson, C. M., Cannon, C. P. Greater benefit of early invasive strategy for unstable angina and non-ST elevation myocardial infarction in United States compared with non-United States patients: a TACTICS-TIMI 18 substudy Crit Pathw Cardiol. 2004;3(2):95-100.

Karha, J., Gibson, C. M., Murphy, S. A., Dibattiste, P. M., Cannon, C. P. Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarction Am J Cardiol. 2004;94(12):1537-9. Abstract

McCullough, P. A., Gibson, C. M., Dibattiste, P. M., Demopoulos, L. A., Murphy, S. A., Weintraub, W. S., Neumann, F. J., Khanal, S., Cannon, C. P. Timing of angiography and revascularization in acute coronary syndromes: an analysis of the TACTICS-TIMI-18 trial J Interv Cardiol. 2004;17(2):81-6.

Morrow, D. A., Sabatine, M. S., Antman, E. M., Cannon, C. P., Braunwald, E., Theroux, P. Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS) Am J Cardiol. 2004;94(6):774-6. Abstract

Petersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., Langer, A., Blazing, M. A., Le-Moigne-Amrani, A., de Lemos, J. A., Nessel, C. C., Harrington, R. A., Ferguson, J. J., Braunwald, E., Califf, R. M. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview JAMA. 2004;292(1):89-96. Abstract

Sabatine, M. S., Morrow, D. A., Giugliano, R. P., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., Weintraub, W. S., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction - A Comparison of the Thrombolysis in Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial Circulation. 2004;109(7):874-880. Abstract

Sadanandan, S., Cannon, C. P., Chekuri, K., Murphy, S. A., Dibattiste, P. M., Morrow, D. A., de Lemos, J. A., Braunwald, E., Gibson, C. M. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(3):564-8. Abstract

Sadanandan, S., Cannon, C. P., Gibson, C. M., Murphy, S. A., DiBattiste, P. M., Braunwald, E. A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):799-803. Abstract

Wiviott, S. D., Cannon, C. P., Morrow, D. A., Murphy, S. A., Gibson, C. M., McCabe, C. H., Sabatine, M. S., Rifai, N., Giugliano, R. P., DiBattiste, P. M., Demopoulos, L. A., Antman, E. M., Braunwald, E. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy Circulation. 2004;109(5):580-6.

Wylie, J. V., Murphy, S. A., Morrow, D. A., de Lemos, J. A., Antman, E. M., Cannon, C. P. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18 Am Heart J. 2004;148(1):173-80. Abstract

Giugliano, R. P., Newby, L. K., Harrington, R. A., Gibson, C. M., Van de Werf, F., Armstrong, P., Montalescot, G., Gilbert, J., Strony, J. T., Califf, R. M., Braunwald, E. The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndrome--study design and rationale Am Heart J. 2005;149(6):994-1002. Abstract

Januzzi, J. L., Jr., Buros, J., Cannon, C. P. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial Clin Cardiol. 2005;28(5):238-42.

Mega, J. L., Morrow, D. A., Sabatine, M. S., Zhao, X. Q., Snapinn, S. M., DiBattiste, P. M., Gibson, C. M., Antman, E. M., Braunwald, E., Theroux, P. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial Am Heart J. 2005;149(5):846-50. Abstract

Moghbeli, N., Kirtane, A. J., Ray, K. K., Murphy, S. A., Gibson, C. M., Braunwald, E., Cannon, C. P. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial) Am J Cardiol. 2005;96(5):635-8.

Morrow, D. A., de Lemos, J. A., Blazing, M. A., Sabatine, M. S., Murphy, S. A., Jarolim, P., White, H. D., Fox, K. A., Califf, R. M., Braunwald, E. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease JAMA. 2005;294(22):2866-71.

Sabatine, M. S., Blake, G. J., Drazner, M. H., Morrow, D. A., Scirica, B. M., Murphy, S. A., McCabe, C. H., Weintraub, W. S., Gibson, C. M., Cannon, C. P. Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment Circulation. 2005;111(10):1217-24.

Steinberg, B. A., Braganza, A. J., Eminowicz, G., Dibattiste, P. M., Flaker, G. C., Murphy, S. A., Cannon, C. P. Are statins being underdosed in clinical practice? Data from TACTICS-TIMI 18 Crit Pathw Cardiol. 2005;4(4):169-73. Abstract

Atar, S., Cannon, C. P., Murphy, S. A., Rosanio, S., Uretsky, B. F., Birnbaum, Y. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial Am Heart J. 2006;151(5):976 e1-6. Abstract

Dumaine, R., Gibson, C. M., Murphy, S. A., Southard, M., Ly, H. Q., McCabe, C. H., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome J Clin Hypertens (Greenwich). 2006;8(5):315-22. Abstract

Gibson, C. M., Karmpaliotis, D., Kosmidou, I., Murphy, S. A., Kirtane, A. J., Budiu, D., Ray, K. K., Herrmann, H. C., Lakkis, N., Kovach, R., French, W., Blankenship, J., Lui, H. H., Palabrica, T., Jennings, L. K., Cohen, D. J., Morrow, D. A. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome Am J Cardiol. 2006;97(10):1473-7.

Januzzi, J. L., Jr., Newby, L. K., Murphy, S. A., Pieper, K., Antman, E. M., Morrow, D. A., Sabatine, M. S., Ohman, E. M., Cannon, C. P., Braunwald, E. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies Am Heart J. 2006;151(2):360-6. Abstract

Kugelmass, A. D., Sadanandan, S., Lakkis, N., Dibattiste, P. M., Robertson, D. H., Demopoulos, L. A., Gibson, C. M., Weintraub, W. S., Murphy, S. A., Cannon, C. P. Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18 Crit Pathw Cardiol. 2006;5(3):167-72.

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Skene, A., McCabe, C. H., Braunwald, E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial Am Heart J. 2006;151(6):1186 e1-9. Abstract

Sabatine, M. S., Morrow, D. A., McCabe, C. H., Antman, E. M., Gibson, C. M., Cannon, C. P. Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction Am Heart J. 2006;151(1):25-31.

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Antman, E. M., Braunwald, E., National Registry of Myocardial, Infarction Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction J Am Coll Cardiol. 2006;47(8):1553-8. Abstract

Cannon, C. P., Husted, S., Harrington, R. A., Scirica, B. M., Emanuelsson, H., Peters, G., Storey, R. F. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial J Am Coll Cardiol. 2007;50(19):1844-51. Abstract

Giugliano, R. P., Wiviott, S. D., Stone, P. H., Simon, D. I., Schweiger, M. J., Bouchard, A., Leesar, M. A., Goulder, M. A., Deitcher, S. R., McCabe, C. H., Braunwald, E. Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial J Am Coll Cardiol. 2007;49(25):2398-407. Abstract

Morrow, D. A., Scirica, B. M., Karwatowska-Prokopczuk, E., Murphy, S. A., Budaj, A., Varshavsky, S., Wolff, A. A., Skene, A., McCabe, C. H., Braunwald, E. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial JAMA. 2007;297(16):1775-83. Abstract

Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P., Verheugt, F. W., Gersh, B. J., McCabe, C. H., Braunwald, E. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2007;116(15):1647-52. Abstract

Storey, R. F., Husted, S., Harrington, R. A., Heptinstall, S., Wilcox, R. G., Peters, G., Wickens, M., Emanuelsson, H., Gurbel, P., Grande, P., Cannon, C. P. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes J Am Coll Cardiol. 2007;50(19):1852-6. Abstract

Ahmed, S., Cannon, C. P., Giugliano, R. P., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E., Gibson, C. M. The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes Int J Cardiol. 2008;131(1):105-12. Abstract

Cannon, C. P. Updated Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) unstable angina/non-ST elevation myocardial infarction critical pathway toolkit Crit Pathw Cardiol. 2008;7(1):43-81. Abstract

Morrow, D. A., Sabatine, M. S., Brennan, M. L., de Lemos, J. A., Murphy, S. A., Ruff, C. T., Rifai, N., Cannon, C. P., Hazen, S. L. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J. 2008;29(9):1096-102.

O'Donoghue, M., Boden, W. E., Braunwald, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., Fox, K. A., Lagerqvist, B., McCullough, P. A., Murphy, S. A., Spacek, R., Swahn, E., Wallentin, L., Windhausen, F., Sabatine, M. S. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis JAMA. 2008;300(1):71-80. Abstract

Husted, S., Harrington, R. A., Cannon, C. P., Storey, R. F., Mitchell, P., Emanuelsson, H. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial Int J Clin Pract. 2009;63(4):667-70. Abstract

Scirica, B. M., Morrow, D. A., Budaj, A., Dalby, A. J., Mohanavelu, S., Qin, J., Aroesty, J., Hedgepeth, C. M., Stone, P. H., Braunwald, E. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2009;53(16):1411-21. Abstract

Wilson, S. R., Sabatine, M. S., Braunwald, E., Sloan, S., Murphy, S. A., Morrow, D. A. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial American heart journal. 2009;158(3):386-91. Abstract

Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., Morrow, D. A. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial Journal of the American College of Cardiology. 2009;53(17):1510-6. Abstract

Bonaca, M., Scirica, B., Sabatine, M., Dalby, A., Spinar, J., Murphy, S. A., Jarolim, P., Braunwald, E., Morrow, D. A. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I J Am Coll Cardiol. 2010;55(19):2118-24. Abstract

Bonaca, Marc P., Kudinova, Anastacia, Kakkar, Rahul, Scirica, Benjamin S., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A. ST2 and the Risk of CV Death or Heart Failure in Patients with Non-ST elevation Acute Coronary Syndromes (NSTE-ACS): Observations from MERLIN-TIMI 36 Circulation. 2010;122(21):NA.

Bonaca, Marc P., Scirica, Bejamin M., Sabatine, Marc S., Jarolim, Petr, Murphy, Sabina A., Chamberlin, Janna S., Rhodes, Daniel W., Southwick, Paula C., Braunwald, Eugene, Morrow, David A. Metalloproteinase PAPP-A and Outcomes in Patients with ACS: Observations from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Husted, S., Storey, R. F., Harrington, R. A., Emanuelsson, H., Cannon, C. P. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel Clin Cardiol. 2010;33(4):206-12. Abstract

Kadakia, M. B., Desai, N. R., Alexander, K. P., Chen, A. Y., Foody, J. M., Cannon, C. P., Wiviott, S. D., Scirica, B. M., National Cardiovascular Data, Registry Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines) JACC Cardiovasc Interv. 2010;3(11):1166-77. Abstract

Kontos, M. C., de Lemos, J. A., Ou, F. S., Wiviott, S. D., Foody, J. M., Newby, L. K., Chen, A., Roe, M. T. Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry Am Heart J. 2010;160(5):819-25. Abstract

Lopes, R. D., Peterson, E. D., Chen, A. Y., Roe, M. T., Wang, T. Y., Ohman, E. M., Magid, D. J., Ho, P. M., Wiviott, S. D., Scirica, B. M., Alexander, K. P. Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry JACC Cardiovasc Interv. 2010;3(6):669-77. Abstract

Mega, J. L., Hochman, J. S., Scirica, B. M., Murphy, S. A., Sloan, S., McCabe, C. H., Merlini, P., Morrow, D. A. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) Circulation. 2010;121(16):1809-17. Abstract

Morrow, D. A., Scirica, B. M., Sabatine, M. S., de Lemos, J. A., Murphy, S. A., Jarolim, P., Theroux, P., Bode, C., Braunwald, E. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial Journal of the American College of Cardiology. 2010;55(12):1189-96. Abstract

Scirica, B. M., Braunwald, E., Belardinelli, L., Hedgepeth, C. M., Spinar, J., Wang, W., Qin, J., Karwatowska-Prokopczuk, E., Verheugt, F. W., Morrow, D. A. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial Circulation. 2010;122(5):455-62. Abstract

Syed, Zeeshan, Scirica, Benjamin M., Mohanavelu, Satishkumar, Morrow, David A., Stultz, Collin M., Guttag, John Association of Heart Rate Turbulence, Deceleration Capacity and Morphologic Variability with Sudden Cardiac Death Following Non-ST-Elevation Acute Coronary Syndrome: Results from the MERLIN-TIMI 36 Trial Circulation. 2010;122(21):NA.

Tanguay, Jean-François, Newby, L. Kristin, Hochman, Judith, Westerhout, Cynthia M., Califf, Robert M., Gibson, C. Michael, Giugliano, Robert P., Harrington, Robert A., Van de Werf, Frans, Armstrong, Paul W. SEX DIFFERENCES IN HIGH-RISK ACUTE CORONARY SYNDROMES: INSIGHTS FROM EARLY-ACS J Am Coll Cardiol. 2010;55(10s1):A120.E1122-A120.E1122.

Wang, Tracy, White, Jennifer A., Giugliano, Robert P., Tricoci, Pierluigi, Harrington, Robert A., Montalescot, Gilles, Zeymer, Uwe, Van de Werf, Frans, Armstrong, Paul W., Braunwald, Eugene, Califf, Robert M., Newby, L. Kristin UPFRONT CLOPIDOGREL USE AND THE EFFICACY AND SAFETY OF EARLY EPTIFIBATIDE USE IN PATIENTS WITH ACUTE CORONARY SYNDROME: AN ANALYSIS FROM THE EARLY VERSUS DELAYED PROVISIONAL EPTIFIBATIDE IN ACUTE CORONARY SYNDROMES (EARLY ACS) TRIAL Journal of the American College of Cardiology. 2010;55(10, Supplement):A47.E451.

Don, C. W., Roe, M. T., Li, S., Fraulo, E., Pomerantsev, E., Palacios, I., Wiviott, S. D. Temporal trends and practice variations in clopidogrel loading doses in patients with non-ST-segment elevation myocardial infarction, from the National Cardiovascular Data Registry Am Heart J. 2011;161(4):689-97. Abstract

Hanna, E. B., Chen, A. Y., Roe, M. T., Wiviott, S. D., Fox, C. S., Saucedo, J. F. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention JACC Cardiovasc Interv. 2011;4(9):1002-8. Abstract

Harkness, J. R., Morrow, D. A., Braunwald, E., Ren, F., Lopez-Sendon, J., Bode, C., Budaj, A., Scirica, B. M. Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial) American journal of cardiology. 2011;108(10):1373-81. Abstract

Kadakia, M. B., Fox, C. S., Scirica, B. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial Heart. 2011;97(21):1782-7. Abstract

Melloni, C., James, S. K., White, J. A., Giugliano, R. P., Harrington, R. A., Huber, K., Tricoci, P., Armstrong, P. W., Van de Werf, F., Montalescot, G., Califf, R. M., Newby, L. K., Early ACS Investigators Safety and efficacy of adjusted-dose eptifibatide in patients with acute coronary syndromes and reduced renal function. Am Heart J. 2011;162(5):884-892. Abstract

Ruff, Christian T., Goodman, Shaun, Hod, Hanoch, Bode, Christoph, Widimsky, Petr, Kiss, Robert G., Contant, Charles F., Crugnale, Sharon E., Moryusef, Angele, Steg, Gabriel, Antman, Elliott M., Sabatine, Marc S. Evaluation of the Efficacy and Safety of Otamixaban vs. Unfractionated Heparin+Eptifibatide in Elderly Patients with Non-St-Elevation Acute Coronary Syndromes in the SEPIA ACS-TIMI 42 Trial Journal of the American College of Cardiology. 2011;57(14, Supplement):E915.

Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., de Lemos, J. L., Braunwald, E., Morrow, D. A. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial European heart journal. 2011;32(6):697-705. Abstract

Bonaca, M. P., Scirica, B. M., Sabatine, M. S., Jarolim, P., Murphy, S. A., Chamberlin, J. S., Rhodes, D. W., Southwick, P. C., Braunwald, E., Morrow, D. A. Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes J Am Coll Cardiol. 2012;60(4):332-8. Abstract

Braunwald, E. Unstable angina and non-ST elevation myocardial infarction Am J Respir Crit Care Med. 2012;185(9):924-32. Abstract

Hoffmann, U., Truong, Q. A., Fleg, J. L., Goehler, A., Gazelle, S., Wiviott, S., Lee, H., Udelson, J. E., Schoenfeld, D., Romicat,, II Design of the Rule Out Myocardial Ischemia/Infarction Using Computer Assisted Tomography: a multicenter randomized comparative effectiveness trial of cardiac computed tomography versus alternative triage strategies in patients with acute chest pain in the emergency department Am Heart J. 2012;163(3):330-8, 338 e1. Abstract

Kohli, P., Bonaca, M. P., Kakkar, R., Kudinova, A. Y., Scirica, B. M., Sabatine, M. S., Murphy, S. A., Braunwald, E., Lee, R. T., Morrow, D. A. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial Clinical chemistry. 2012;58(1):257-66. Abstract

Lopes, R. D., White, J. A., Tricoci, P., White, H. D., Armstrong, P. W., Braunwald, E., Giugliano, R. P., Harrington, R. A., Lewis, B. S., Brogan, G. X., Jr., Gibson, C. M., Califf, R. M., Newby, L. K. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: Insights from the EARLY ACS trial International journal of cardiology. 2012;NA(NA):NA. Abstract

Maddox, T. M., Ho, P. M., Tsai, T. T., Wang, T. Y., Li, S., Peng, S. A., Wiviott, S. D., Masoudi, F. A., Rumsfeld, J. S. Clopidogrel use and hospital quality in medically managed patients with non-ST-segment-elevation myocardial infarction Circ Cardiovasc Qual Outcomes. 2012;5(4):523-31. Abstract

O'Malley, Ryan G., Bonaca, Marc, Sabatine, Marc, Scirica, Benjamin, Jarolim, Petr, Conrad, Michael, Murphy, Sabina, Braunwald, Eugene, Morrow, David PROGNOSTIC PERFORMANCE OF A SINGLE-MOLECULE HIGH-SENSITIVITY CARDIAC TROPONIN ASSAY AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN-TIMI 36 Journal of the American College of Cardiology. 2012;59(13):E402-E402.

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P., Califf, R. M., Harrington, R. A., Newby, L. K. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes Circulation. 2012;126(1):41-9. Abstract

Rasoul S, van't Hof A, Clare R, Atar D, James S, Tanguay J, Betriu A, Brogan G, Giugliano R, Newby LK Routine Early Eptifibatide, Infarct Size and Outcomes in Non-ST segment Elevation Acute Coronary Syndrome Patients with Elevated Troponins on Admission J Am Coll Cardiol. 2012;59(13):A121.

Roe, M. T., White, J. A., Kaul, P., Tricoci, P., Lokhnygina, Y., Miller, C. D., van't Hof, A. W., Montalescot, G., James, S. K., Saucedo, J., Ohman, E. M., Pollack, C. V., Jr., Hochman, J. S., Armstrong, P. W., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Califf, R. M., Newby, L. K. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial Circ Cardiovasc Qual Outcomes. 2012;5(2):205-13. Abstract

Roysland, R., Bonaca, M. P., Omland, T., Sabatine, M., Murphy, S. A., Scirica, B. M., Bjerre, M., Flyvbjerg, A., Braunwald, E., Morrow, D. A. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes Heart. 2012;98(10):786-91. Abstract

Subherwal, S., Peterson, E. D., Chen, A. Y., Roe, M. T., Washam, J. B., Gage, B. F., Bach, R. G., Bhatt, D. L., Wiviott, S. D., Lopes, R. D., Alexander, K. P., Wang, T. Y. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry Circulation. 2012;125(11):1414-23. Abstract

Truong, Quynh A., Hayden, Douglas, Woodard, Pamela K., Kirby, Ruth, Chou, Eric T., Wiviott, Stephen D., Fleg, Jerome L., Schoenfeld, David A., Udelson, James E., Hoffmann, Udo Abstract 12596: Women Benefit Most from Early CCTA Compared to Standard ED Evaluation for Acute Chest Pain: The ROMICAT II Trial Circulation. 2012;126(21 Supplement):A12596.

Udell, Jacob A, Bonaca, Marc P, Braunwald, Eugene, Hoffman, Elain P, Mohanavelu, Satishkumar, Jarolim, Petr, Michael, Conrad J, Desai, Nihar R, Sabatine, Marc S, Morrow, David A, Scirica, Benjamin M Abstract 11434: Low Level Elevation of Highly-Sensitive Cardiac Troponin I after Non-ST Elevation Acute Coronary Syndrome and Early Risk of Cardiac Ischemia and Ventricular Tachycardia: Analysis from MERLIN-TIMI 36 Circulation. 2012;126(21 Supplement):A11434.

Udell, Jacob A, O'Donoghue, Michelle L, Braunwald, Eugene, Scirica, Benjamin M, Wiviott, Stephen D, Bansilal, Sameer, Hoffman, Elaine B, Sabatine, Marc S, Cannon, Christopher P Abstract 15090: Evaluation of Right Bundle Branch Block for Risk Prediction and Guiding Revascularization Strategy in Patients with Non-ST-Elevation Acute Coronary Syndrome in the TACTICS-TIMI 18 Trial Circulation. 2012;126(21 Supplement):A15090.

Vavalle, J. P., Lopes, R. D., Chen, A. Y., Newby, L. K., Wang, T. Y., Shah, B. R., Ho, P. M., Wiviott, S. D., Peterson, E. D., Roe, M. T., Granger, C. B. Hospital length of stay in patients with non-ST-segment elevation myocardial infarction Am J Med. 2012;125(11):1085-94. Abstract

Zeymer, Uwe, Clare, Robert, Schweiger, Marc, van't Hof, Arnoud, Hochman, Judith, James, Stefan, White, Harvey, Widimsky, Petr, Betriu, Amadeo, Bode, Christoph, Califf, Robert, Harrington, Robert, Giugliano, Robert, Gibson, C. Michael, Newby, L. Kristin FREQUENCY, CLINICAL AND ANGIOGRAPHIC CHARACTERISTICS, AND OUTCOMES OF HIGH-RISK NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES PATIENTS WITH LEFT CIRCUMFLEX CULPRIT LESIONS Journal of the American College of Cardiology. 2012;59(13, Supplement):E405.

Bagai, A., White, J. A., Lokhnygina, Y., Giugliano, R. P., Van de Werf, F., Montalescot, G., Armstrong, P. W., Tricoci, P., Gibson, C. M., Califf, R. M., Harrington, R. A., Newby, L. K. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial Am Heart J. 2013;166(3):466-473 e1. Abstract

Bohula May, E. A., Bonaca, M. P., Jarolim, P., Antman, E. M., Braunwald, E., Giugliano, R. P., Newby, L. K., Sabatine, M. S., Morrow, D. A. Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non-ST-Elevation Acute Coronary Syndrome Clin Chem. 2013;NA(NA):NA. Abstract

Braunwald, E., Morrow, D. A. Unstable angina: is it time for a requiem? Circulation. 2013;127(24):2452-7.

Desai, N. R., Peterson, E. D., Chen, A. Y., Wiviott, S. D., Sabatine, M. S., Alexander, K. P., Roe, M. T., Shah, B. R. Balancing the risk of mortality and major bleeding in the treatment of NSTEMI patients - A report from the National Cardiovascular Data Registry Am Heart J. 2013;166(6):1043-1049 e1. Abstract

Giraldez, R. R., Clare, R. M., Lopes, R. D., Dalby, A. J., Prabhakaran, D., Brogan, G. X., Jr., Giugliano, R. P., James, S. K., Tanguay, J. F., Pollack, C. V., Jr., Harrington, R. A., Braunwald, E., Newby, L. K. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome Am Heart J. 2013;165(6):918-925 e2. Abstract

Grinstein, J., Bonaca, M., Sabatine, M., Jarolim, P., Conrad, M. J., Braunwald, E. B., Giugliano, R. P., Newby, L. K., Morrow, D. A., Timi Study Group, Prognostic Implications of Low-Level Cardiac Troponin Elevation Using the High-Sensitivity Assay for Cardiac Troponin T: Results from EARLY ACS & SEPIA-TIMI 42 Journal of the American College of Cardiology. 2013;61(10):A27.

Kaul, P., Tanguay, J. F., Newby, L. K., Hochman, J. S., Westerhout, C. M., Califf, R. M., Tricoci, P., Gibson, C. M., Giugliano, R. P., Harrington, R. A., Van de Werf, F., Armstrong, P. W. Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial Am Heart J. 2013;166(4):723-8. Abstract

Klutstein, M. W., Westerhout, C. M., Armstrong, P. W., Giugliano, R. P., Lewis, B. S., Gibson, C. M., Lutchmedial, S., Widimsky, P., Steg, P. G., Dalby, A., Zeymer, U., Van de Werf, F., Harrington, R. A., Newby, L. K., Rao, S. V. Radial versus femoral access, bleeding and ischemic events in patients with non-ST-segment elevation acute coronary syndrome managed with an invasive strategy Am Heart J. 2013;165(4):583-590 e1. Abstract

Lee, D., Goodman, S. G., Fox, K. A., DeYoung, J. P., Lai, C. C., Bhatt, D. L., Huynh, T., Yan, R. T., Gallo, R., Steg, P. G., Yan, A. T. Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension Am Heart J. 2013;166(4):716-22. Abstract

Leonardi, S., Truffa, A. A., Neely, M. L., Tricoci, P., White, H. D., Gibson, C. M., Wilson, M., Stone, G. W., Harrington, R. A., Bhatt, D. L., Mahaffey, K. W. A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial Heart. 2013;99(17):1282-7. Abstract

Lopes, R. D., White, J. A., Tricoci, P., White, H. D., Armstrong, P. W., Braunwald, E., Giugliano, R. P., Harrington, R. A., Lewis, B. S., Brogan, G. X., Jr., Gibson, C. M., Califf, R. M., Newby, L. K. Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial Int J Cardiol. 2013;167(6):2580-7. Abstract

Mohareb, M., Goodman, S. G., Yan, R. T., Bhatt, D. L., Elbarouni, B., Deyoung, J. P., Gallo, R., Kornder, J. M., Welsh, R. C., Saposnik, G., Rose, B., Wong, G. C., Grondin, F. R., Yan, A. T., on behalf of the Canadian, Grace Grace Canrace investigators Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease Int J Cardiol. 2013;NA(NA):NA. Abstract

Piccini, J. P., White, J. A., Mehta, R. H., Lokhnygina, Y., Al-Khatib, S. M., Tricoci, P., Califf, R. M., Harrington, R. A., Newby, L. K., Pollack, C. V., Jr., Montalescot, G., Van de Werf, F., Gibson, C. M., Giugliano, R. P. Response to letter regarding article, "sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment elevation acute coronary syndromes" Circulation. 2013;127(20):e634.

Rose, J. J., Newby, L. K., Broderick, S., Chiswell, K., Van de Werf, F., Armstrong, P. W., Mahaffey, K. W., Harrington, R. A., Ohman, E. M., Giugliano, R. P., Goodman, S. G., White, H. D., Califf, R. M., Granger, C. B., Lopes, R. D. Left Bundle Branch Block in Non-ST-Segment Elevation Acute Coronary Syndromes: Incidence, Angiographic Characteristics, and Clinical Outcomes J Am Coll Cardiol. 2013;61(13):1461-3.

Ruff, C. T., Moryusef, A, Umez-Eronini, A., Hoffman, Elain P., Gaudin, C., Antman, E., Sabatine, M., Timi Study Group Evaluation of the Efficacy and Safety of Otamixaban versus Unfractionated Heparin+Eptifibatide in Patients with Non-ST-Elevation Acute Coronary Syndromes by PCI in the SEPIA-ACS1 TIMI 42 Trial Journal of the American College of Cardiology. 2013;61(10):A25.

Scirica, B., Nieminen, T., Pegler, J. R. M., Tavares, C., Pagotto, V. P. F., Kanas, A. F., Sobrado, M. F., Nearing, B., Cho, J. I., Morrow, D., Belardinelli, L., Verrier, R., Harvard Medical School T-Wave Alternans (TWA) is Associated with Cardiovascular Mortality and NSVTin the MERLIN-TIMI 36 Trial of Ranolazine versus Placebo in Patients with Non-ST Segment Elevation Acute Coronary Syndrome Journal of the American College of Cardiology. 2013;61(10):64.

Steg, P. G., Mehta, S. R., Pollack, C. V., Jr., Bode, C., Cohen, M., French, W. J., Hoekstra, J., Rao, S. V., Ruzyllo, W., Ruiz-Nodar, J. M., Sabate, M., Widimsky, P., Kiss, R. G., Navarro Estrada, J. L., Hod, H., Kerkar, P., Guneri, S., Sezer, M., Ruda, M., Nicolau, J. C., Cavallini, C., Ebrahim, I., Petrov, I., Kim, J. H., Jeong, M. H., Ramos Lopez, G. A., Laanmets, P., Kovar, F., Gaudin, C., Fanouillere, K. C., Minini, P., Hoffman, E. B., Moryusef, A., Wiviott, S. D., Sabatine, M. S., T. A. O. Investigators Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial JAMA. 2013;310(11):1145-55. Abstract

Tricoci, P., Leonardi, S., White, J., White, H. D., Armstrong, P. W., Montalescot, G., Giugliano, R. P., Gibson, C. M., Van de Werf, F., Califf, R. M., Harrington, R. A., Braunwald, E., Mahaffey, K. W., Newby, L. K. Cardiac Troponin after Percutaneous Coronary Intervention and 1-Year Mortality in NSTE ACS Using Systematic Evaluation of Biomarker Trends J Am Coll Cardiol. 2013;NA(NA):NA. Abstract

Udell, Jacob A, Morrow, David A, Jarolim, Petr, Sloan, Sarah, Hoffman, Elaine B, O'Donnell, Thomas F, Vora, Amit V, Omland, Torbjorn, Solomon, Scott D, Pfeffer, Marc A, Braunwald, Eugene, Sabatine, Marc S Abstract 10291: Fibroblast Growth Factor (FGF)-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease Circulation. 2013;128(22 Supplement):A10291.

Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, Cornel JH, Himmelmann A, Giannitsis E, Harrington RA, Held C, Husted S, Katus HA, Mahaffey KW, Steg PG, Storey RF, James SK; PLATO study group. Biomarkers in Relation to the Effects of Ticagrelor Compared with Clopidogrel in Non-ST-Elevation Acute Coronary Syndrome Patients Managed with or without In-Hospital Revascularization: A Substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation. 2013;129:293-303. Abstract

Wiviott, S. D., White, H. D., Ohman, E. M., Fox, K. A., Armstrong, P. W., Prabhakaran, D., Hafley, G., Lokhnygina, Y., Boden, W. E., Hamm, C., Clemmensen, P., Nicolau, J. C., Menozzi, A., Ruzyllo, W., Widimsky, P., Oto, A., Leiva-Pons, J., Pavlides, G., Winters, K. J., Roe, M. T., Bhatt, D. L. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial Lancet. 2013;382(9892):605-13. Abstract

Bonaca MP, O'Malley RG, Murphy SA, Jarolim P, Conrad MJ, Braunwald E, Sabatine MS, Morrow DA Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36 Eur Heart J Acute Cardiovasc Care. 2014:Epub ahead of print. Abstract

Lindholm D, Varenhorst C, Cannon CP, Harrington RA, Himmelmann A, Maya J, Husted S, Steg PG, Cornel JH, Storey RF, Stevens SR, Wallentin L, James SK. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014;35:2083-93. Abstract

May, Erin Ann Bohula, Bonaca, Marc, Scirica, Benjamin, Kuder, Julia, Murphy, Sabina, Jarolim, Petr, Sabatine, Marc, Morrow, David GROWTH DIFFERENTIATION FACTOR-15 LEVEL PREDICTS RECURRENT CARDIOVASCULAR EVENTS IN PATIENTS WITH AN ACUTE CORONARY SYNDROME IN MERLIN-TIMI 36 Journal of the American College of Cardiology. 2014;63(12, Supplement):A20.

Nieminen, T., Scirica, B. M., Pegler, J. R., Tavares, C., Pagotto, V. P., Kanas, A. F., Sobrado, M. F., Nearing, B. D., Umez-Eronini, A. A., Morrow, D. A., Belardinelli, L., Verrier, R. L. Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TIMI 36 Trial of Ranolazine Versus Placebo Am J Cardiol. 2014;NA(NA):NA. Abstract

O'Malley, R. G., Bonaca, M. P., Scirica, B. M., Murphy, S. A., Jarolim, P., Sabatine, M. S., Braunwald, E., Morrow, D. A. Prognostic Performance of Multiple Biomarkers in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN-TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36) J Am Coll Cardiol. 2014;63(16):1644-53. Abstract

Patel, J. H., Gupta, R., Roe, M. T., Peng, S. A., Wiviott, S. D., Saucedo, J. F. Influence of Presenting Electrocardiographic Findings on the Treatment and Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction Am J Cardiol. 2014;113(2):256-61. Abstract

Rhee, J. W., Wiviott, S. D., Scirica, B. M., Gibson, C. M., Murphy, S. A., Bonaca, M. P., Morrow, D. A., Mega, J. L. Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Syndrome Clin Cardiol. 2014;NA(NA):NA. Abstract

Xian, Y., Chen, A. Y., Thomas, L., Roe, M. T., Subherwal, S., Cannon, C. P., Pollack, C. V., Jr., Fonarow, G. C., Kosiborod, M., Peterson, E. D., Alexander, K. P. Sources of Hospital-Level Variation in Major Bleeding Among Patients With Non-ST-Segment Elevation Myocardial Infarction: A Report From the National Cardiovascular Data Registry (NCDR) Circ Cardiovasc Qual Outcomes. 2014;7(2):236-43. Abstract

Desai, Nihar, Peterson, E., Chen, A., Wiviott, S., Sabatine, M., Alexander, K. P., Roe, M., Shah, B. Balancing the Risk of Mortality and Major Bleeding in the Treatment of NSTEMI Patients – A Report from the NCDR American Heart Journal. NA;NA(NA):NA.